The experiments addressing the on- and off-tumor effects of inducible high affinity (028) CD38-CAR T cells indicated that gradual decay of CAR expression after DOX removal not only allows the rapid and effective control of the off-tumor toxic effects, but may also generate a small, albeit a temporary therapeutic window in which the anti-tumor effects can be maintained. The gene discussed is CD38; the disease is neoplasm.